Company profile: Allon Therapeutics
1.1 - Company Overview
Company description
- Provider of clinical-stage biopharmaceutical drug development for neurodegenerative diseases, with lead product Davunetide intranasal in Phase IIa clinical trials for Alzheimer's disease, schizophrenia cognitive impairment, and frontotemporal.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Allon Therapeutics
AC Immune
HQ: Switzerland
Website
- Description: Provider of therapeutic and diagnostic products targeting misfolded proteins in neurodegenerative diseases. A Swiss clinical-stage biopharma with three candidates in trials, its pipeline includes ACI-24.060 (anti-Abeta), Semorinemab (anti-Tau), ACI-35.030 (anti-pTau), Morphomer Tau, PI-2620 (Tau-PET tracer), and ACI-7104.056 (anti-alpha-synuclein).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AC Immune company profile →
Biogen
HQ: United States
Website
- Description: Provider of innovative biotechnology therapies in development for neurological and neurodegenerative diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biogen company profile →
HMNC Brain Health
HQ: Germany
Website
- Description: Provider of precision medicine in psychiatry, based in Munich, developing patented genetic tests and combining those with innovative exclusively in-licensed medications, resulting in precise therapies for depression and other neuropsychiatric disorders; founded in 2010, this privately held biotech company develops machine learning-enabled companion diagnostics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HMNC Brain Health company profile →
Winston Labs
HQ: United States
Website
- Description: Provider of pain management products, engaged in their development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Winston Labs company profile →
Cassava Sciences
HQ: United States
Website
- Description: Provider of an investigational oral drug, Simufilam, for Alzheimer’s disease that stabilizes altered filamin A in the brain; currently in Phase III trials. Offers clinical trial programs (rethinkALZ and refocusALZ) to evaluate efficacy and safety of Simufilam, and an Expanded Access program for patients not eligible for trials with serious or life-threatening conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cassava Sciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Allon Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Allon Therapeutics
2.2 - Growth funds investing in similar companies to Allon Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Allon Therapeutics
4.2 - Public trading comparable groups for Allon Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →